AbbVie M15-566
Back to Drug Development Trials
![]()
Drug Development Trials
About the trial
A Phase 2 Multiple Dose, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Subjects with Early Alzheimer’s Disease (M15-566)
